New patent for Exeltis Usa drug SLYND

Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch – Make …


New patent for Boehringer Ingelheim drug JENTADUETO

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are eleven patents…
The post New patent for Boehringer Ingelheim drug JENTADUETO a…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog